Jamp Pharma Corporation
Fabricant québécois de médicaments génériques et produits pharmaceutiques.
Les signaux additionnels (documents, emplois, communiqués, contacts…) sont des bonus : leur absence est normale selon le type d'organisation et ne réduit pas la visibilité.
12 signaux
JAMP Pharma Group Among Quebec’s 300 Largest Companies in 2026
JAMP Pharma Group is proud to be ranked among the 300 largest companies in Quebec in 2026, according to the list published by Les Affaires. This recognition reflects our organization’s growth, the dedication of our teams, and the trust of our partners. Thank you to our employees, partners, and customers who contribute to this collective […]
JAMP Pharma Group Donates $75,000 to the Pierre-Boucher Hospital Foundation
JAMP Pharma Group is proud to donate $75,000 to the Pierre-Boucher Hospital Foundation as part of the “Avec vous pour la vie!” campaign. As a Quebec-based company, our responsibility does not end at the doors of our facilities. Supporting organizations that tangibly improve access to care and patients’ quality of life is an integral part […]
JAMP Pharma Group Expands Oncology Portfolio with PrJAMP Enzalutamide
A new generic option of Enzalutamide, an oncology medication used for the treatment of certain stages of prostate cancer2. It is an orally administered antiandrogen. JAMP Pharma Group is launching PrJAMP Enzalutamide, a generic alternative to the reference product PrXtandi® (marketed in Canada by Astellas Pharma Canada Inc.). With the largest selection of generic medications […]
Strategic Expansion: Laboratoire Suisse and Cosmetic Import Continue Their Growth with the Acquisition of Les Laboratoires Colba’s Assets
Boucherville, Quebec, December 2nd, 2025 – The JAMP Pharma Group, a Canadian leader in the pharmaceutical sector, announced today that its over-the-counter natural health and cosmetic products division, through its subsidiaries Laboratoire Suisse Inc. and Cosmetic Import Ltd, is acquiring the assets of Les Laboratoires Colba Inc., including the Racine de Vie®, Alpen Secrets®, and […]
Important information on JAMP Spironolactone 25 mg Tablets: Possible oversized tablets
Dear Pharmacist, This communication is to inform you that certain bottles of JAMP Spironolactone 25 mg tablets, from lot numbers AT250543A and AT250544A, may contain tablets that are thicker (see image below). This is not a recall communication, please do not return the JAMP Spironolactone 25 mg bottles that you currently have in stock as […]
JAMP Pharma Group launches Pr Pexegra® (pegfilgrastim) and Pr Filra® (filgrastim), two new biosimilar therapeutic options in oncology
JAMP Pharma Group launches PrPexegra®, a biosimilar alternative to the reference product PrNeulasta® (commercialized in Canada by Amgen Canada Inc.). JAMP Pharma Group also launches PrFilra®, a biosimilar alternative to the reference product PrNeupogen® (commercialized in Canada by Amgen Canada Inc.). JAMP Pharma Group, through its BioJAMP® division, is strengthening its portfolio of biosimilar products. […]
Orimed Pharma announces the availability in Canada of Pr Solufy TM, a new liquid solution of aripiprazole
Orimed Pharma, an affiliate of the JAMP Pharma Corporation, is launching PrSolufyTM, a liquid solution of aripiprazole. This new formulation offers an alternative to current solid forms, which could make it easier to administer treatment to certain patients. PrSolufyTM is the first product in a future portfolio of liquid solutions, underscoring Orimed Pharma and the […]
Two electrifying new products are igniting the Swical Energy range!
Laboratoire Suisse is proud to announce the launch of two new products in its Swical Energy line up: Swical Energy Daily and Swical Energy Immunity. Proudly made in Quebec, these caffeine-free natural health products offer a healthy alternative to energy drinks, providing energy and vitality through a fusion of vitamins and plant extracts. Experience the same […]
JAMP Pharma Group Announces the Commercial Launch and Availability of Pr JAMP Ipratropium HFA
JAMP Pharma Group launches Ipratropium HFA, offering the only generic alternative in Canada to the reference product PrAtrovent® HFA (marketed in Canada by Boehringer Ingelheim). With the launch of PrJAMP Ipratropium HFA, the JAMP Pharma Group, a leader in product launches1, broadens its respiratory health offering, giving healthcare professionals and patients better access to more […]
Laboratoire Suisse unveils its latest innovation – Swical Collagen Rejuvenate
Laboratoire Suisse is pleased to present its latest addition to the Swical family: Swical Collagen Rejuvenate. Proudly made in Quebec, this liquid collagen is a perfect representation of Laboratoire Suisse’s ongoing commitment to innovate and offer products that contribute to the well-being of consumers. Swical Collagen Rejuvenate packs 2500 mg of collagen per dose, along […]
Adorable unveils its new range of body care products for children!
Adorable, a brand from the Wampole division, unveils its new range of body care products for children made from 98% natural ingredients and manufactured in Quebec. Designed to bring a touch of natural softness to precious moments with your little treasures, the range includes the Gentle Wash Head to Toe (https://www.wampole.ca/product/gentle-wash-head-toe), the Comforting Bubble Bath […]
JAMP Pharma Group Acquires a Pharmaceutical Manufacturing Facility in Lévis, Quebec
This transaction strengthens JAMP Pharma Group’s position as an industry leader and addresses the increasing demand for locally manufactured pharmaceutical products. Boucherville, Quebec, February 29, 2024 — JAMP Pharma Group, a leading company in the Canadian pharmaceutical industry for over 35 years, announces today, subject to Superior Court approval and the fulfillment of customary closing […]
Vous représentez Jamp Pharma ?
Revendiquez cette fiche pour contrôler les données publiées et devenir la source officielle consultée par les agents IA.
Revendiquer cette fiche →